Burgess, Rochelle A. http://orcid.org/0000-0001-9749-7065
Shittu, Funmilayo
Iuliano, Agnese
Haruna, Ibrahim
Valentine, Paula
Bakare, Ayobami Adebayo
Colbourn, Tim
Graham, Hamish R.
McCollum, Eric D.
Falade, Adegoke G.
King, Carina
Ahmed, Tahlil
Ahmar, Samy
Cassar, Christine
Isah, Adamu
Osebi, Adams
Magama, Abdullahi
Seriki, Ibrahim
Olowookere, Temitayo Folorunso
McCalla, Matt
Uchendu, Obioma
Salako, Julius
Bakare, Damola
Olojede, Omotayo
,
Funding for this research was provided by:
GlaxoSmithKline - Save the Children Foundation Partnership (82603743)
Article History
Received: 11 June 2022
Accepted: 20 April 2023
First Online: 7 June 2023
Declarations
:
: Ethical approvals were provided by the University College London Research Ethics Committee (ref: 3433/004) and the Jigawa State Health Research Ethics Committee (MOH/SEC.3/S/830/1). All participants completed consent forms prior to participation in the study.
: All images are published with the consent of participations who signed study consent forms prior to publication. We have opted to blur faces as an additional layer of protection for communities.
: HG, EM and CK are advisors to Lifebox Foundation on pulse oximetry. AAB, AGF and HG are board members for Oxygen for Life Initiative (OLI), a private non-profit that has provided services to the INSPIRING project. IH and PV are employed by Save the Children UK who are part of the partnership funding the research. TFO and MM are employees of and stockholders in GSK, a multinational for-profit pharmaceutical company that produces pharmaceutical products for childhood pneumonia, including a SARS-CoV2 vaccine.